Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma — Giulia Francesca Manfredi (2024) | RDL Network
Richard S. Finn, Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae‐You Kim, Masatoshi Kudo, В. В. Бредер, Philippe Merle, Ahmed O. Kaseb, Daneng Li, Wendy Verret, Derek-Zhen Xu, Sairy Hernandez, Juan Liu, Chen Huang, Sohail Mulla, Yulei Wang, Ho Yeong Lim, Andrew X. Zhu, Ann‐Lii Cheng
Sohyun Hwang, Dong Jun Shin, Beodeul Kang, Haeyoun Kang, Sung Hwan Lee, Jung Sun Kim, Je‐Gun Joung, Suyog Jain, Steven R. Olsen, Lars Becker, Richard S. Finn, Josep M. Llovet, Gwangil Kim, Chan Kim, Hong Jae Chon
Mara Persano, M. Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Hye Yeon Lim, José Presa, Gianluca Masi, Francesca Bergamo, Massimo Iavarone, Giuseppe Cabibbo, Francesco Giuseppe Foschi, F. Piscaglia, Stefano Cascinu, M. Scartozzi
Mara Persano, M. Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, F. Finkelmeier, Hyoseob Lim, José Presa, Gianluca Masi, Francesca Bergamo, Massimo Iavarone, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Fabio Piscaglia, S. Cascinu, M. Scartozzi
Discussion(0)
No comments yet. Be the first to comment.